Johnson & Johnson vaccine 'very promising,' says infectious disease specialist

Calling the clinical trial 'thorough,' infectious disease specialist Dr. Matthew Oughton says Johnson & Johnson's single-shot COVID-19 vaccine is also easier to handle logistically compared to approved vaccines in Canada.